Gilead has handed back a next-gen hepatitis B (HBV) antiviral to Assembly Biosciences, while the two companies continue to partner on other assets. It means Assembly is now back in sole control of ABI ...

The UK Health Security Agency (UKHSA) said that as of 5pm on Wednesday, 15 cases of meningitis have been confirmed and a further 12 are under investigation ...

The Centers for Disease Control and Prevention released a report March 12 on the effectiveness of the flu vaccine for the ...

Scientists have found a way to make one of the most aggressive brain tumors vulnerable to the immune system. A single injection of a modified virus can invade glioblastoma, kill cancer cells, and ...

T he recent reimbursement of Bimzelx (bimekizumab) in Ireland represents an important step forward in access to treatment for people living with immune-mediated diseases, includin ...

Respiratory syncytial virus, a common illness that can resemble a cold, is still sending infants to the hospital at higher ...